Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Frenay

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Bulletin Du Cancer|January 1, 1997
[Tamoxifen adjuvant delays early breast cancer. Results of a cooperative randomized trial]T Delozier, O Switsers, J Y Génot, et al.
Journal of Chromatography. A|February 21, 1997
Liquid chromatography-mass spectrometry with on-line solid-phase extraction by a restricted-access C18 precolumn for direct plasma and urine injectionR A van der Hoeven, A J Hofte, M Frenay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcomeM C Etienne, J L Formento, C Lebrun-Frenay, et al.
Familial Cancer|September 5, 2009
Molecular study of CEBPA in familial hematological malignanciesR El Abed, V Bourdon, L Huiart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971M J van den Bent, M J B Taphoorn, A A Brandes, et al.
Neurology|September 15, 2004
Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomasV H J M Triebels, M J B Taphoorn, A A Brandes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†B Chauffert, L Feuvret, F Bonnetain, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1996
Boron neutron capture irradiation: setting up a clinical programme in NiceJ P Pignol, P Chauvel, P Paquis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2011
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor GroupR Stupp, A Tosoni, J E C Bromberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiformeM J van den Bent, W Grisold, D Frappaz, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Bulletin Du Cancer|January 1, 1997
[Tamoxifen adjuvant delays early breast cancer. Results of a cooperative randomized trial]T Delozier, O Switsers, J Y Génot, et al.
Journal of Chromatography. A|February 21, 1997
Liquid chromatography-mass spectrometry with on-line solid-phase extraction by a restricted-access C18 precolumn for direct plasma and urine injectionR A van der Hoeven, A J Hofte, M Frenay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 31, 1998
Epidermal growth factor receptor and labeling index are independent prognostic factors in glial tumor outcomeM C Etienne, J L Formento, C Lebrun-Frenay, et al.
Familial Cancer|September 5, 2009
Molecular study of CEBPA in familial hematological malignanciesR El Abed, V Bourdon, L Huiart, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 28, 2003
Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971M J van den Bent, M J B Taphoorn, A A Brandes, et al.
Neurology|September 15, 2004
Salvage PCV chemotherapy for temozolomide-resistant oligodendrogliomasV H J M Triebels, M J B Taphoorn, A A Brandes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 12, 2014
Randomized phase II trial of irinotecan and bevacizumab as neo-adjuvant and adjuvant to temozolomide-based chemoradiation compared with temozolomide-chemoradiation for unresectable glioblastoma: final results of the TEMAVIR study from ANOCEF†B Chauffert, L Feuvret, F Bonnetain, et al.
Bulletin Du Cancer. Radiotherapie : Journal De La Societe Francaise Du Cancer : Organe De La Societe Francaise De Radiotherapie Oncologique|January 1, 1996
Boron neutron capture irradiation: setting up a clinical programme in NiceJ P Pignol, P Chauvel, P Paquis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2011
Sagopilone (ZK-EPO, ZK 219477) for recurrent glioblastoma. A phase II multicenter trial by the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor GroupR Stupp, A Tosoni, J E C Bromberg, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
European Organization for Research and Treatment of Cancer (EORTC) open label phase II study on glufosfamide administered as a 60-minute infusion every 3 weeks in recurrent glioblastoma multiformeM J van den Bent, W Grisold, D Frappaz, et al.
Pageof 8